Yttrium Y 90 ibritumomab tiuxetan

Jump to navigationJump to search

An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.

Sponsor: shop now Free Shipping On Order Over $50 !